Custom service
High-throughput Protein Production
Hundreds of constructs expressed, screened and ranked in parallel.
Most protein failures are construct failures, and they are discovered one at a time. A truncation that would have solved solubility is tried after three months of fighting a construct that was never going to fold; a boundary chosen from a domain prediction turns out to be wrong by ten residues. High-throughput production turns that into a parallel experiment: express every reasonable variant, let the data choose.
The campaign runs on automation. Genes are synthesised or cloned into a common vector backbone in a 96- or 384-well format, small-scale expressions are run in deep-well plates under a matrix of temperatures and induction conditions, and soluble expression is scored by SDS-PAGE of the soluble and insoluble fractions. Positives are purified on automated affinity columns and ranked by yield, monomer content and activity.
The deliverable is not just protein; it is a map. Which boundaries express, which tags help, which constructs aggregate, and what yield to expect at scale. That map decides the preparative production, and it prevents the common outcome of scaling a construct that was never the best option — only the first one tried.
High-throughput production is the right first move for a difficult protein whose construct is uncertain, for protein families where several members are needed, and for projects where the cost of a failed preparative expression exceeds the cost of screening.
It is over-engineering for a protein that expresses on the first try, and it cannot rescue a target that is fundamentally unexpressable — no construct will fix an unstable or self-cleaving protein.
Every construct in the campaign is sequence-verified before expression, and every screen result is archived with its gel image. Positives are released with purity, monomer content and activity data; the campaign report includes the full ranking table.
Service Highlights
- Construct libraries. 10–384 variants covering boundaries, tags, mutations and homologues, expressed side by side under identical conditions.
- Condition matrix. Temperature, induction strength and media varied per plate to find the condition that separates soluble expression from aggregation.
- Automated scoring. Soluble fraction, yield and monomer content quantified per construct, with SDS-PAGE images retained for every well.
- Automated purification. Affinity capture in plate format, followed by analytical SEC for monomer content of every positive.
- Homologue screening. Orthologs expressed in parallel, since solubility often differs more between species than between constructs of the same protein.
- Scale-up handoff. The winning construct moves to preparative expression with its documented condition and yield expectation.
How the work runs
Variant design
Domain boundaries from sequence analysis and structure prediction, tag and fusion options, and homologues selected to cover the plausible design space.
Cloning and verification
Genes synthesised or cloned in parallel, with every construct sequence-verified before expression.
Small-scale expression
Deep-well plate expressions under a condition matrix; soluble and insoluble fractions analysed by SDS-PAGE.
Automated purification
Positives purified by affinity capture, followed by analytical SEC to measure monomer content.
Activity ranking
Binding or enzymatic assays run where available, so the construct chosen is active, not merely soluble.
Report and scale-up
A ranked table with yields, purity and activity per construct, plus the recommended condition for preparative production.
Specifications & timeline
- Format
- 96- and 384-well plate expression
- Constructs
- 10–384 per campaign; larger on request
- Expression hosts
- E. coli primarily; insect cell screening available
- Scoring
- Soluble yield, purity, monomer content by analytical SEC, activity where assay exists
- Timeline
- 3–5 weeks per campaign
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.